Other coronary interventions

Salvatore Brugaletta interviews Tiffany Patterson about the study design and results that she presented during the ESC Congress 2023 in Amsterdam.

The ARREST trial showed that in patients without STEMI, expedited transfer to a cardiac arrest centre after resuscitated OHCA was not associated with decreased 30-day mortality compared...

Cardiovascular disease in particular ischaemic heart disease is the leading cause of mortality worldwide. International guidelines provide recommendations on the best evidence-based care for patients. At the ESC Congress 2023 in Amsterdam, the ESC 2023 Guidelines on Acute Coronary Syndromes were presented and published1. Vijay Kunadian provides...

Nicola Ryan provides her take on the final results of OPT-BIRISK which were presented by Yaling Han during the ESC 2023 congress in Amsterdam.

Note the assumptions in this article are based on the presentation alone as the trial has not yet been published.

Cardiogenic shock is a complication that occurs in 5 to 10 % of MIs, and mortality remains very high. Although early revascularisation can save lives, inotropes still have their limitations, and data on the impact of mechanical circulatory assistance is limited. Watch this session to find...

Madji Saada, James Nolan and Ariel Roguin describe radiation in the cathlab before setting out the basic rules to follow to be protected against it.

The cathlab is potentially the most irradiating environment in which a healthcare professional can work and, over a long period, it can...

Ali Nazmi Calik interviews Gregg Stone about the results of the meta-analysis which he presented during the ESC Congress 2023 in Amsterdam. It showed that intravascular imaging-guided PCI (IVUS or OCT) reduces target lesion failure, cardiac death, myocardial infarction, and revascularization compared to angiography-guided PCI.

Ali Nazmi Calik interviews Duk-Woo Park & Do-Yoon Kang regarding the results of the OCTIVUS trial which were presented during the ESC Congress 2023 in Amsterdam.

Key message is that optical coherence tomography (OCT) is non-inferior to intravascular ultrasound (IVUS) for guiding percutaneous coronary intervention (PCI).

Claudio Laudani and Daniele Giacoppo report the main results of the ILUMIEN IV trial presented by Ziad Ali, from the St. Francis Hospital, Roslyn, and Clinical Trials Center, Cardiovascular Research Foundation, New York, in a Hot Line session at the European Society of Cardiology congress 2023...

Aaysha Cader interviews Masahiro Natsuaki about the design and results of the STOPDAPT-3 trial which he presented during the ESC Congress 2023 in Amsterdam.

Prasugrel monotherapy after PCI with drug-eluting stents was not superior to dual-antiplatelet therapy (DAPT) for major bleeding but was non-inferior for cardiovascular events...